Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

charlotte lozier institute

charlotte lozier institute

2 results

Filter Results By

Filter Applied. Clear All

Latest Posts

March 25, 2024 Filed: CLI Amicus Brief in Idaho’s Moyle v. United States EMTALA Case Filed: CLI Amicus Brief in Idaho’s Moyle v. United States EMTALA Case March 22, 2024 Fact Sheet: Three Problems with the FDA’s Abortion Drugs Complications Data Fact Sheet: Three Problems with the FDA’s Abortion Drugs Complications Data March 21, 2024 Filed: CLI Amicus Brief in SCOTUS Case FDA v. Alliance for Hippocratic Medicine Filed: CLI Amicus Brief in SCOTUS Case FDA v. Alliance for Hippocratic Medicine
Reset All Filters
2 results
charlotte lozier institute

Charlotte Lozier Institute Adds Five New Scholars

The Charlotte Lozier Institute (CLI) has added five experts in science and bioethics to the ranks of its associate scholars’ team.

charlotte-lozier-institute Charlotte Lozier Institute
November 23, 2016
ClosePlease login
featured-image
charlotte lozier institute

Comments Submitted to Dept. of Health and Human Services on Title X Funding

On October 7, the Charlotte Lozier Institute (CLI) filed two separate comments to the Department of Health and Human Services regarding its proposed rule on entities qualifying for the government’s Title X family planning funds. The proposed rule (Compliance with Title X Requirements by Project Recipients in Selecting Subrecipients, 81 FR 61639-61646), which was published September 7, seeks to preclude states from taking action to “restrict participation by certain types of providers as subrecipients in the Title X Program…”

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image